Agios Pharmaceuticals
AGIO • NASDAQ
Agios Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Brian Goff, with a market cap of $1.9B.
Market Cap$1.9B
Employees386.0
CEOBrian Goff
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsApr 29, 2026 · In 2 weeksQ1 2026
Financials
Agios Pharmaceuticals FAQ
Common questions about Agios Pharmaceuticals
Agios Pharmaceuticals is scheduled to report earnings for Q1 2026 on April 29, 2026. Analysts estimate revenue of $14.2M.
Agios Pharmaceuticals has approximately 386 employees.